Cargando…

The Hematopoietic Niche in Myeloproliferative Neoplasms

Specialized microanatomical areas of the bone marrow provide the signals that are mandatory for the maintenance and regulation of hematopoietic stem cells (HSCs) and progenitor cells. A complex microenvironment adjacent to the marrow vasculature (vascular niche) and close to the endosteum (endosteal...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitt-Graeff, Annette H., Nitschke, Roland, Zeiser, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677214/
https://www.ncbi.nlm.nih.gov/pubmed/26696752
http://dx.doi.org/10.1155/2015/347270
_version_ 1782405293537230848
author Schmitt-Graeff, Annette H.
Nitschke, Roland
Zeiser, Robert
author_facet Schmitt-Graeff, Annette H.
Nitschke, Roland
Zeiser, Robert
author_sort Schmitt-Graeff, Annette H.
collection PubMed
description Specialized microanatomical areas of the bone marrow provide the signals that are mandatory for the maintenance and regulation of hematopoietic stem cells (HSCs) and progenitor cells. A complex microenvironment adjacent to the marrow vasculature (vascular niche) and close to the endosteum (endosteal niche) harbors multiple cell types including mesenchymal stromal cells and their derivatives such as CAR cells expressing high levels of chemokines C-X-C motif ligand 12 and early osteoblastic lineage cells, endothelial cells, and megakaryocytes. The characterization of the cellular and molecular networks operating in the HSC niche has opened new perspectives for the understanding of the bidirectional cross-talk between HSCs and stromal cell populations in normal and malignant conditions. A structural and functional remodeling of the niche may contribute to the development of myeloproliferative neoplasms (MPN). Malignant HSCs may alter the function and survival of MSCs that do not belong to the neoplastic clone. For example, a regression of nestin(+) MSCs by apoptosis has been attributed to neuroglial damage in MPN. Nonneoplastic MSCs in turn can promote aggressiveness and drug resistance of malignant cells. In the future, strategies to counteract the pathological interaction between the niche and neoplastic HSCs may offer additional treatment strategies for MPN patients.
format Online
Article
Text
id pubmed-4677214
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-46772142015-12-22 The Hematopoietic Niche in Myeloproliferative Neoplasms Schmitt-Graeff, Annette H. Nitschke, Roland Zeiser, Robert Mediators Inflamm Review Article Specialized microanatomical areas of the bone marrow provide the signals that are mandatory for the maintenance and regulation of hematopoietic stem cells (HSCs) and progenitor cells. A complex microenvironment adjacent to the marrow vasculature (vascular niche) and close to the endosteum (endosteal niche) harbors multiple cell types including mesenchymal stromal cells and their derivatives such as CAR cells expressing high levels of chemokines C-X-C motif ligand 12 and early osteoblastic lineage cells, endothelial cells, and megakaryocytes. The characterization of the cellular and molecular networks operating in the HSC niche has opened new perspectives for the understanding of the bidirectional cross-talk between HSCs and stromal cell populations in normal and malignant conditions. A structural and functional remodeling of the niche may contribute to the development of myeloproliferative neoplasms (MPN). Malignant HSCs may alter the function and survival of MSCs that do not belong to the neoplastic clone. For example, a regression of nestin(+) MSCs by apoptosis has been attributed to neuroglial damage in MPN. Nonneoplastic MSCs in turn can promote aggressiveness and drug resistance of malignant cells. In the future, strategies to counteract the pathological interaction between the niche and neoplastic HSCs may offer additional treatment strategies for MPN patients. Hindawi Publishing Corporation 2015 2015-11-30 /pmc/articles/PMC4677214/ /pubmed/26696752 http://dx.doi.org/10.1155/2015/347270 Text en Copyright © 2015 Annette H. Schmitt-Graeff et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Schmitt-Graeff, Annette H.
Nitschke, Roland
Zeiser, Robert
The Hematopoietic Niche in Myeloproliferative Neoplasms
title The Hematopoietic Niche in Myeloproliferative Neoplasms
title_full The Hematopoietic Niche in Myeloproliferative Neoplasms
title_fullStr The Hematopoietic Niche in Myeloproliferative Neoplasms
title_full_unstemmed The Hematopoietic Niche in Myeloproliferative Neoplasms
title_short The Hematopoietic Niche in Myeloproliferative Neoplasms
title_sort hematopoietic niche in myeloproliferative neoplasms
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677214/
https://www.ncbi.nlm.nih.gov/pubmed/26696752
http://dx.doi.org/10.1155/2015/347270
work_keys_str_mv AT schmittgraeffannetteh thehematopoieticnicheinmyeloproliferativeneoplasms
AT nitschkeroland thehematopoieticnicheinmyeloproliferativeneoplasms
AT zeiserrobert thehematopoieticnicheinmyeloproliferativeneoplasms
AT schmittgraeffannetteh hematopoieticnicheinmyeloproliferativeneoplasms
AT nitschkeroland hematopoieticnicheinmyeloproliferativeneoplasms
AT zeiserrobert hematopoieticnicheinmyeloproliferativeneoplasms